Summer 2016

YONDELIS (trabectedin) and HALAVEN (eribulin) are the first chemotherapies originally derived from marine life, although they are now synthetically made. Both drugs are approved for the treatment of liposarcoma, and Yondelis also for the treatment of leiomyosarcoma.

Letters from you, our readers.

The cleanliness of drinking water can vary, so for those who are immunocompromised, it can be a good idea to take precautions.

A nonprofit is partnering with performance artists to stimulate end-of-life discussions.

Thousands of first responders and citizens developed cancer following the September 11 terror attacks.

After being diagnosed with pancreatic cancer, a PR executive created on online database where patients can connect with others who share their diagnosis and also get reliable information.

After their use skyrocketed, the FDA placed regulations on electronic cigarettes, gaining praise from many cancer organizations.

TV star Shannen Doherty discusses some of the rough times she went through during her breast cancer battle.

Deborah S. Derman created an adult coloring book to help patients cope with difficult times.

There are many promising and important points in Vice President Biden's Cancer Moonshot, but Len Lichtenfeld believes that prioritizing clinical trials is one of the more vital ones.

Virginia nurses raised awareness about skin cancer risk by evaluating people’s faces for sun damage.

Serving as a caregiver to a loved one with cancer is particularly challenging, and training could make the experience more manageable.

With growing evidence that they can help patients and their families heal, art installations and exhibits are becoming more prevalent in cancer centers.

Evolving strategies for the elimination of nausea and vomiting are making treatment more comfortable for many patients with cancer.

The treatment paradigm for soft tissue sarcomas is changing as the condition is becoming better understood.

For military veterans with cancer, obtaining government-funded health care can constitute a tough fight.

The 50 cancers under the umbrella of soft tissue sarcoma are marked by genetic chaos, and a growing understanding of these mutations may lead to new treatments.

Visits from trained therapy animals and their handlers can boost the moods of patients undergoing treatment for cancer.